The Effect of Placental Cord Drainage on Postpartum Blood Loss
NCT05610345 is an interventional trial sponsored by University of Tennessee. As of 21 Nov 2026, it is completed. It studies Postpartum Hemorrhage. The registry lists an enrollment of 71 participants at 1 site in 1 country. The registry lists a start date of 12 Nov 2022 and a primary completion date of 1 Jun 2023.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT05610345 |
| Status | Completed |
| Study type | Interventional trial |
| Lead sponsor | University of Tennessee |
| Enrollment | 71 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Postpartum Hemorrhage |
| Start | 12 Nov 2022 |
| Primary completion | 1 Jun 2023 |
| Study completion | 1 Jun 2023 |
| Last update posted | 13 Feb 2024 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- John Schorge, MD, FACS
Regional One Health
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Regional One Health
Memphis
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT05610345
Each answer restates registry values shown on this page.
What is NCT05610345?
NCT05610345 is an interventional trial sponsored by University of Tennessee. It studies Postpartum Hemorrhage.
Who leads NCT05610345?
The registry names John Schorge, MD, FACS (study chair, Regional One Health) as the overall official.
Where does NCT05610345 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When did NCT05610345 end?
The registry lists a primary completion date of 1 Jun 2023 and a study completion date of 1 Jun 2023. The sponsor last updated the record on 13 Feb 2024.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.